1"use strict";(self.webpackChunkmedi_website=self.webpackChunkmedi_website||[]).push([[6060],{3268:function(e,a,t){t.r(a),t.d(a,{default:function(){return d}});var l=t(96540),r=t(47444),n=t(46500),o=t(24794),i=t(33360),c=t(32532),s=t(3702),m=t.p+"static/CoolCryoposterISMICS2025desktop-94704e260caaba96e431482adfe8f5e0.jpg",g=t.p+"static/CoolCryoposterISMICS2025mobile-7276baebfbaf66b9b21cc906796918d7.jpg";var d=()=>{const e=(0,r.vc)(n.y$),{0:a,1:d}=(0,l.useState)(!1);return l.createElement(l.Fragment,null,l.createElement("section",{className:"flex w-full mt-0 lg:mt-20 items-center h-[50vh] lg:h-full"},l.createElement(c.S,{src:"../../images/productCoolCryoHeroPhoto.jpg",alt:"CoolCryo photo",className:"lg:bg-center flex w-auto lg:w-full h-full lg:min-w-[200px] object-cover lg:min-h-[280px] lg:h-[640px] max-h-[100vh] lg:max-h-[640px] relative min-h-[100%] max-w-full",loading:"lazy",__imageData:t(15627)}),l.createElement(i.H,{className:"left-[50%] -translate-x-[50%] absolute top-[192px] lg:top-[440px] lg:-mt-[20px] w-full !items-start"},l.createElement("div",{className:"flex flex-col gap-6"},l.createElement("h1",{className:"flex flex-col font-semibold text-white leading-[1.4] lg:leading-[1.2] pl-0 lg:pl-20",style:{textShadow:"0 0 10px rgba(0, 0, 0, 0.7)"}},l.createElement("span",{className:"text-3xl lg:text-6xl mb-2 lg:mb-2"},"CoolCryo"),l.createElement("span",{className:"text-2xl lg:text-4xl"},"pl-PL"==e?"Szybka i skuteczna krioablacja":"Quick and Powerful Cryoablation"))))),l.createElement("section",{className:"mt-10 lg:mt-20 mb-10 lg:mb-0 lg:-ml-18"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-6 lg:gap-20"},l.createElement("div",{className:"flex flex-col order-1 lg:order-2 w-full lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4"},"pl-PL"==e?"System do krioablacji serca":"Cardiac Cryoablation System"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&"CoolCryo to system do krioablacji serca wykorzystujÄ
cy ciekÅy azot jako medium chÅodzÄ
ce. CiekÅy azot jest powszechnie dostÄpny, szeroko stosowany i należy do najtaÅszych Årodków chÅodzÄ
cych, co znaczÄ
co obniża koszt zabiegu i zwiÄksza jego dostÄpnoÅÄ. GÅównÄ
zaletÄ
systemu CoolCryo jest podgrzewana, formowalna koÅcówka, która umożliwia szybkie przeprowadzenie krioablacji, skracajÄ
c tym samym czas trwania zabiegu.","en-US"===e&&"CoolCryo is a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium. Liquid nitrogen is widely available, commonly used, and one of the most cost-effective cooling agents, which significantly reduces the cost of the procedure and increases its accessibility. One of the key advantages of CoolCryo is its heated, formable tip, which enables fast ablation and thus shortens the duration of the procedure.")),l.createElement("div",{className:"!flex-col !items-start pl-0 lg:-pl-16 w-full lg:w-1/2 order-2 lg:order-1"},l.createElement("iframe",{className:"rounded-lg",width:"100%",height:"300",src:"https://www.youtube.com/embed/IGCefPTv7Bw",title:"CoolCryo teaser",frameBorder:"0",allow:"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share",referrerPolicy:"strict-origin-when-cross-origin",allowFullScreen:!0}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-10 pb-4 lg:pt-20 lg:pb-12 mt-6 lg:mt-20 mb-0 lg:mb-20 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20 pb-4 lg:pb-0"},l.createElement("h2",{className:"flex lg:hidden text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Problem":"The Problem"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h2",{className:"hidden lg:flex text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Problem":"The Problem"),l.createElement("h3",{className:"text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Migotanie przedsionków to najczÄstsze zaburzenie rytmu serca, powodujÄ
ce nieregularne i czÄsto zbyt szybkie bicie przedsionków.":"Atrial fibrillation (AFib) is the most common heart rhythm disorder that causes the upper chambers of the heart to beat irregularly and often rapidly."),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Nieleczone migotanie przedsionków może prowadziÄ do poważnych powikÅaÅ, takich jak udar mózgu, niewydolnoÅÄ serca czy przewlekÅe zmÄczenie, znaczÄ
co obniżajÄ
c jakoÅÄ Å¼ycia. Do typowych problemów zwiÄ
zanych z tym schorzeniem należÄ
:"),"en-US"===e&&l.createElement(l.Fragment,null,"Uncontrolled atrial fibrillation can lead to serious complications, including stroke, heart failure, and chronic fatigueâsignificantly reducing quality of life. Common issues include:")),l.createElement("ul",{className:"flex flex-col text-base lg:text-xl list-disc list-outside max-w-[740px] mb-0 lg:mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-2 text-[#03466C] font-semibold"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"nawet piÄciokrotny wzrost ryzyka udaru mózgu"),l.createElement("li",{className:"pl-2"},"objawy takie jak dusznoÅÄ, zawroty gÅowy czy koÅatanie serca"),l.createElement("li",{className:"pl-2"},"inne nietypowe objawy, które czÄsto pozostajÄ
niewykryte")),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",null,"stroke risk up to 5à higher"),l.createElement("li",null,"breathlessness, dizziness, palpitations"),l.createElement("li",null,"other unusual symptoms that often go unnoticed")))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},l.createElement(c.S,{src:"../../images/atrialfibrillation.jpg",alt:"PacePress schema",className:"w-full h-auto rounded-lg shadow-lg max-w-[640px]",__imageData:t(88271)}))))),l.createElement("section",{className:"w-full flex justify-center items-center mt-10 lg:mt-0 mb-0 lg:mb-0"},l.createElement(i.H,null,l.createElement("div",{className:"w-full flex flex-col-reverse lg:flex-row-reverse gap-2 lg:gap-0"},l.createElement("div",{className:"flex flex-col lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"SkutecznoÅÄ przezskórnej ablacji - kiedy pomaga, a kiedy może nie wystarczyÄ":"When Catheter Ablation Works â and When It May Not"),l.createElement("ul",{className:"flex flex-col text-base lg:text-xl list-disc list-outside max-w-[740px] mb-0 lg:mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-4"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Ablacja przezskórna to skuteczne leczenie migotania przedsionków oraz innych arytmii. Usuwa niewielkie obszary tkanki serca odpowiadajÄ
ce za nieprawidÅowe sygnaÅy, przywracajÄ
c prawidÅowy rytm i ÅagodzÄ
c objawy."),l.createElement("li",{className:"pl-2"},"SkutecznoÅÄ zależy od stopnia zaawansowania choroby. W przypadku zaawansowanej lub dÅugotrwaÅej choroby efekty mogÄ
byÄ mniej trwaÅe. Czasem potrzebne sÄ
kolejne zabiegi jak np. ablacja chirurgiczna.")),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Catheter ablation is an effective treatment for atrial fibrillation (AFib) and other arrhythmias. It targets small areas of heart tissue causing abnormal signals, helping restore normal rhythm and reduce symptoms."),l.createElement("li",{className:"pl-2"},"Its success varies with disease stage. In advanced or long-standing AFib, results may not last. Some patients need extra treatments such as surgical ablation.")))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start ml-0 lg:-ml-10"},l.createElement(c.S,{src:"../../images/cardiacablation.jpg",alt:"PacePress schema",className:"w-full h-auto rounded-lg max-w-[520px]",__imageData:t(24663)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-6 pb-4 lg:pt-20 lg:pb-20 mt-6 lg:mt-16 mb-0 lg:mb-20 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20"},l.createElement("h3",{className:"flex lg:hidden text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Unikalna konstrukcja oraz funkcjonalnoÅci":"Unique design and ke
1y features"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Unikalna konstrukcja oraz funkcjonalnoÅci":"Unique design and key features"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Innowacyjny system krioablacji oparty na ciekÅym azocie"),"en-US"===e&&l.createElement(l.Fragment,null,"Innovative liquid nitrogen-based cryoablation system")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"KsztaÅtowana koÅcówka z aluminium do precyzyjnych oraz szybszych zabiegów"),"en-US"===e&&l.createElement(l.Fragment,null,"Moldable aluminum tip for precise and faster procedures")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Regulowana gÅÄbokoÅÄ ablacji dziÄki ustawieniom czasu i temperatury"),"en-US"===e&&l.createElement(l.Fragment,null,"Adjustable ablation depth via time and temperature settings")),l.createElement("p",{className:"text-base lg:text-base text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"ŹródÅo (3): Oparte na danych eksperymentalnych Medinice uzyskanych w trakcie badaÅ przedklinicznych oraz na danych pochodzÄ
cych z innych dostÄpnych źródeÅ."),"en-US"===e&&l.createElement(l.Fragment,null,"Reference (3): Based on Medinice experimental data during preclinical studies and data from other available sources."))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/CoolCryofreezingGraphsPL.jpg",alt:"Krzywe mrożenia CoolCryo vs konkurencja",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(26256)}):l.createElement(c.S,{src:"../../images/CoolCryofreezingGraphsEN.jpg",alt:"Freezing curves CoolCryo vs competition",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(85522)}))))),l.createElement("section",{className:"w-full flex justify-center items-center mt-10 lg:mt-0 mb-0 lg:mb-0"},l.createElement(i.H,null,l.createElement("div",{className:"w-full flex flex-col-reverse lg:flex-row-reverse gap-2 lg:gap-0"},l.createElement("div",{className:"flex flex-col lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Czy jedno mrożenie jest równe innemu mrożeniu?":"Freezing equals freezing?"),l.createElement("ul",{className:"flex flex-col text-base lg:text-xl list-disc list-outside max-w-[740px] mb-0 lg:mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-4"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Szybkie zamrażanie - cztery razy szybciej niż przy użyciu innych wyrobów medycznych - skuteczniejsza martwica",l.createElement("sup",{className:"text-sm"},"2")),l.createElement("li",{className:"pl-2"},"Liniowe gÅÄbokie zamrażanie dziÄki najniższej temperaturze kriogenu oraz najwyższej pojemnoÅci cieplnej kriogenu, wiÄksza objÄtoÅÄ zmian",l.createElement("sup",{className:"text-sm"},"1"))),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Quick freezing - four times faster than with other devices - more efficient necrosis",l.createElement("sup",{className:"text-sm"},"2")),l.createElement("li",{className:"pl-2"},"Linear deep freezing due to coldest cryogen temperature and highest cryogen heat capacity, higher volume of lesions",l.createElement("sup",{className:"text-sm"},"1")))),l.createElement("h3",{className:"text-sm lg:text-base font-semibold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"ŹródÅa:":"References:"),l.createElement("ul",{className:"flex flex-col text-sm lg:text-sm list-decimal list-outside max-w-[740px] mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-2"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},'Goette, Julia, et al. "Freezing equals freezing? Performance of two cryoablation devices in concomitant mitral valve repair". The Thoracic and Cardiovascular Surgeon 64.08 (2016): 672-678.'),l.createElement("li",{className:"pl-2"},'Baust, John G., and Andrew A. Gage. "The molecular basis of cryosurgery." BJU international 95.9 (2005).'),l.createElement("li",{className:"pl-2"},"Oparte na danych eksperymentalnych Medinice uzyskanych w trakcie badaÅ przedkl
1inicznych oraz na danych pochodzÄ
cych z innych dostÄpnych źródeÅ.")),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},'Goette, Julia, et al. "Freezing equals freezing? Performance of two cryoablation devices in concomitant mitral valve repair". The Thoracic and Cardiovascular Surgeon 64.08 (2016): 672-678.'),l.createElement("li",{className:"pl-2"},'Baust, John G., and Andrew A. Gage. "The molecular basis of cryosurgery." BJU international 95.9 (2005).'),l.createElement("li",{className:"pl-2"},"Based on Medinice experimental data during preclinical studies and data from other available sources.")))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start ml-0 lg:-ml-10"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/CoolCryofreezingEqfreezingPL.jpg",alt:"Mrożenie CoolCryo vs konkurencja",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(81145)}):l.createElement(c.S,{src:"../../images/CoolCryofreezingEqfreezingEN.jpg",alt:"Freezing CoolCryo vs competition",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(89362)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-10 pb-4 lg:py-20 mt-6 lg:mt-16 mb-0 lg:mb-20 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20"},l.createElement("h3",{className:"flex lg:hidden text-xl lg:text-xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Bariery i ograniczenia chirurgicznej krioablacji":"Barriers and limitations of surgical cryoablation"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Bariery i ograniczenia chirurgicznej krioablacji":"Barriers and limitations of surgical cryoablation"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Kardiochirurdzy zwracajÄ
uwagÄ na niskÄ
ergonomiÄ obecnych systemów oraz wydÅużony czas procedury. Ograniczenia to m.in. sÅaba moc mrożenia, trudnoÅÄ krioablacji grubych tkanek, brak możliwoÅci krioablacji na bijÄ
cym sercu, wysoki koszt sprzÄtu i ograniczony dostÄp do czynnika chÅodzÄ
cego. Podczas operacji zastawki mitralnej 46% chirurgów nie widzi barier, jednak 23% wskazuje na wydÅużenie czasu zaklemowania, a 13% na wysokie ryzyko pacjentów jako powody unikania tych rozwiÄ
zaÅ."),"en-US"===e&&l.createElement(l.Fragment,null,"Surgeons point to the low usability of current systems and prolonged application time. Key limitations include insufficient freezing power, difficulty cryoablating thick tissues, inability to perform ablation on a beating heart, high equipment costs, and limited access to coolant. During mitral valve surgery, 46% of surgeons report no barriers, but some cite added cross-clamp time (23%) or high patient risk (13%) as reasons preventing wider use of existing systems.")),l.createElement("p",{className:"text-sm lg:text-sm text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8 italic"},"pl-PL"===e&&l.createElement(l.Fragment,null,"ŹródÅo: Mehaffey, J. Hunter, et al. âBarriers to atrial fibrillation ablation during mitral valve surgery.â The Journal of thoracic and cardiovascular surgery 165.2 (2023): 650-658."),"en-US"===e&&l.createElement(l.Fragment,null,'Source: Mehaffey, J. Hunter, et al. "Barriers to atrial fibrillation ablation during mitral valve surgery." The Journal of thoracic and cardiovascular surgery 165.2 (2023): 650-658.'))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/challenges-in-surgical-ablation-PL.png",alt:"Wyzwania ablacji chirurgicznej",className:"w-full h-auto rounded-lg max-w-[640px]",__imageData:t(4711)}):l.createElement(c.S,{src:"../../images/challenges-in-surgical-ablation-EN.png",alt:"Challenges in surgical ablation",className:"w-full h-auto rounded-lg max-w-[640px]",__imageData:t(33061)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-0 pb-0 lg:pb-4 lg:py-0 mt-10 lg:mt-0 mb-0 lg:mb-2"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2"},l.createElement("h2",{className:"flex lg:hidden text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"RozwiÄ
zanie":"The Solution"),l.createElement("h3",{className:"flex lg:hidden text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"CoolCryo do krioablacji kardiochirurgicznej":"CoolCryo for surgical ablation"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-2 pl-0 lg:pl-4 pr-0 lg:pr-16"},l.createElement("h2",{className:"hidden lg:flex text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"RozwiÄ
zanie":"The Solution"),l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"CoolCryo do krioablacji kardiochirurgicznej":"CoolCryo for surgical ablation"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Co najmniej czterokrotnie szybsza procedura krioablacji chirurgicznej"),"en-US"===e&&l.createElement(l.Fragment,null,"At least four times faster procedure for surgical ablation")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"MożliwoÅÄ krioablacji bardzo grubych tkanek, potencjalnie także komory"),"en-US"===e&&l.createElement(l.Fragment,null,"Possibility of ablating very thick t
1issues, potentially also the ventricle")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"MożliwoÅÄ krioablacji na bijÄ
cym sercu"),"en-US"===e&&l.createElement(l.Fragment,null,"Possibility of ablating on a beating heart")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"DostÄp przez sternotomiÄ lub metody maÅoinwazyjne"),"en-US"===e&&l.createElement(l.Fragment,null,"Access through sternotomy or minimally invasive methods"))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-1 ml-0 lg:-ml-5"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/CoolCryoPL.jpg",alt:"CoolCryo",className:"w-full h-auto max-w-[520px] rounded-md",__imageData:t(96613)}):l.createElement(c.S,{src:"../../images/CoolCryoEN.jpg",alt:"CoolCryo",className:"w-full h-auto max-w-[520px] rounded-md",__imageData:t(57203)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-6 pb-4 lg:pt-20 lg:pb-20 mt-6 lg:mt-12 mb-0 lg:mb-4 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20"},l.createElement("h3",{className:"flex lg:hidden text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Opatentowana konstrukcja oraz funkcjonalnoÅci":"Patented design and functionalities"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Globalna ochrona patentowa":"Global patent protection"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Nasza technologia CoolCryo jest chroniona przez szeroki portfel patentów miÄdzynarodowych, podkreÅlajÄ
cy nasze zaangażowanie w innowacje. Z patentami przyznanymi na gÅównych obszarach takich jak Polska, Stany Zjednoczone, Kanada, Chiny, Japonia, Korea PoÅudniowa, Indie, EPO i WPO."),"en-US"===e&&l.createElement(l.Fragment,null,"Our CoolCryo technology is protected by a wide portfolio of international patents, highlighting our commitment to innovation. Patents granted in major areas such as Poland, US, Canada, China, Japan, South Korea, India, EPO, and WPO.")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"CoolCryo jest chroniony przez kompleksowÄ
i szerokÄ
strategiÄ ochrony wÅasnoÅci intelektualnej. Ta szeroka ochrona gwarantuje unikalnoÅÄ, niezawodnoÅÄ i przewagÄ konkurencyjnÄ
naszej technologii na caÅym Åwiecie."),"en-US"===e&&l.createElement(l.Fragment,null,"CoolCryo is protected by a comprehensive and wide-ranging intellectual property protection strategy. This broad protection ensures uniqueness, reliability, and competitive advantage of our technology worldwide."))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},l.createElement(c.S,{src:"../../images/CoolCryopatents.png",alt:"CoolCryo patents",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(42547)}))))),l.createElement("section",{className:"w-full flex justify-center items-center mt-0 lg:mt-16 mb-0 lg:mb-0"},l.createElement(i.H,null,l.createElement("div",{className:"w-full flex flex-col-reverse lg:flex-row-reverse gap-2 lg:gap-10"},l.createElement("div",{className:"flex flex-col lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Zastosowanie CoolCryo w czÄstoskurczu komorowym":"Potential application of CoolCryo in ventricular tachycardia"),l.createElement("p",{className:"text-base lg:text-lg text-start lg:text-start max-w-[740px] mb-0 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Niedawny przypadek kliniczny pokazuje obiecujÄ
ce zastosowanie systemu CoolCryo w leczeniu tachykardii komorowej (VT). ChoÄ farmakoterapia zwykle jest leczeniem pierwszego wyboru w burzy elektrycznej, nawrotowe arytmie mogÄ
wymagaÄ sympatektomii piersiowej lub kardiochirurgicznej ablacji, gdy metody przezcewnikowe zawodzÄ
. U pacjentów, dla których zatrzymanie pracy
1serca podczas zabiegu jest zbyt ryzykowne, preferuje siÄ ablacjÄ na bijÄ
cym sercu. Tradycyjne systemy krioablacyjne oparte na argonie lub podtlenku azotu czÄsto nie dajÄ
wystarczajÄ
cej mocy. CoolCryo, wykorzystujÄ
c ciekÅy azot, pokonuje te ograniczenia, umożliwiajÄ
c skutecznÄ
krioablacjÄ niezależnie od gruboÅci Åciany serca czy przepÅywu krwi.",l.createElement("a",{className:"hidden lg:flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:m},"Klinknij tutaj aby poznaÄ wiÄcej szczegóÅów",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"})),l.createElement("a",{className:"lg:hidden flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:g},"Klinknij tutaj aby poznaÄ wiÄcej szczegóÅów",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"}))),"en-US"===e&&l.createElement(l.Fragment,null,"A recent use case highlights a promising new application of CoolCryo in the treatment of ventricular tachycardia (VT). While pharmacotherapy is typically the first-line treatment for electrical storm, recurrent ventricular arrhythmias may require thoracic sympathectomy or surgical ablation, particularly when catheter-based techniques are ineffective. In patients who cannot tolerate heart arrest, beating-heart ablation is preferred; however, conventional cryoablation systems using argon or nitrous oxide often lack adequate freezing power. CoolCryo, leveraging liquid nitrogenâs superior freezing capacity, addresses these limitations by enabling effective cryoablation regardless of heart wall thickness or blood flow.",l.createElement("a",{className:"hidden lg:flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:m},"Click here for more details",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"})),l.createElement("a",{className:"lg:hidden flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:g},"Click here for more details",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"}))))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:pl-20 mt-10 lg:mt-0"},l.createElement("iframe",{width:"100%",src:"https://www.youtube.com/embed/BOAWu6qbwJQ",title:"CoolCryo Fakty TVN",frameBorder:"0",allow:"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share",referrerPolicy:"strict-origin-when-cross-origin",allowFullScreen:!0,className:"rounded-xl h-[200px] lg:h-[400px]"}))))),l.createElement("section",{className:"w-full flex justify-start lg:justify-center items-start lg:items-center pt-8 pb-8 lg:pt-10 lg:pb-16 m-0 lg:mt-0 mb-0 lg:mb-0 pl-6 lg:pl-0"},l.createElement(o.Link,{to:"/products",className:"flex w-max justify-start items-start font-bold text-lg py-2 lg:py-2 px-8 rounded-full text-white bg-blue-600 border-2 border-solid border-blue-600 hover:bg-blue-800 hover:border-blue-800 transition-all duration-300 ease-in-out transform hover:scale-105 mt-2"},"pl-PL"==e?"WiÄcej o naszych innowacjach":"More about our innovations")))}},3702:function(e,a,t){var l=t(96540),r=t(5556),n=t.n(r),o=["color","size","title","className"];function i(){return i=Object.assign?Object.assign.bind():function(e){for(var a=1;a<arguments.length;a++){var t=arguments[a];for(var l in t)({}).hasOwnProperty.call(t,l)&&(e[l]=t[l])}return e},i.apply(null,arguments)}var c=(0,l.forwardRef)((function(e,a){var t=e.color,r=void 0===t?"currentColor":t,n=e.size,c=void 0===n?"1em":n,s=e.title,m=void 0===s?null:s,g=e.className,d=void 0===g?"":g,p=function(e,a){if(null==e)return{};var t,l,r=function(e,a){if(null==e)return{};var t={};for(var l in e)if({}.hasOwnProperty.call(e,l)){if(-1!==a.indexOf(l))continue;t[l]=e[l]}return t}(e,a);if(Object.getOwnPropertySymbols){var n=Object.getOwnPropertySymbols(e);for(l=0;l<n.length;l++)t=n[l],-1===a.indexOf(t)&&{}.propertyIsEnumerable.call(e,t)&&(r[t]=e[t])}return r}(e,o);return l.createElement("svg",i({ref:a,xmlns:"http://www.w3.org/2000/svg",viewBox:"0 0 16 16",width:c,height:c,fill:r,className:["bi","bi-arrow-right",d].filter(
1Boolean).join(" ")},p),m?l.createElement("title",null,m):null,l.createElement("path",{fillRule:"evenodd",d:"M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8"}))}));c.propTypes={color:n().string,size:n().oneOfType([n().string,n().number]),title:n().string,className:n().string},a.A=c},4711:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/bd82de3e08cfe16aa47652d57209fd12/c5670/challenges-in-surgical-ablation-PL.png","srcSet":"/static/bd82de3e08cfe16aa47652d57209fd12/13212/challenges-in-surgical-ablation-PL.png 159w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/81cc0/challenges-in-surgical-ablation-PL.png 318w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/c5670/challenges-in-surgical-ablation-PL.png 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/bd82de3e08cfe16aa47652d57209fd12/4feb0/challenges-in-surgical-ablation-PL.webp 159w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/60d91/c
1hallenges-in-surgical-ablation-PL.webp 318w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/2cd3f/challenges-in-surgical-ablation-PL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},15627:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#787878","images":{"fallback":{"src":"/static/d965a6ea59cdbe208fd4e9b2f7b56381/5267c/productCoolCryoHeroPhoto.jpg","srcSet":"/static/d965a6ea59cdbe208fd4e9b2f7b56381/fa695/productCoolCryoHeroPhoto.jpg 480w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/a0d3e/productCoolCryoHeroPhoto.jpg 960w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/5267c/productCoolCryoHeroPhoto.jpg 1920w","sizes":"(min-width: 1920px) 1920px, 100vw"},"sources":[{"srcSet":"/static/d965a6ea59cdbe208fd4e9b2f7b56381/95a23/productCoolCryoHeroPhoto.webp 480w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/5bdbe/productCoolCryoHeroPhoto.webp 960w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/9c00f/productCoolCryoHeroPhoto.webp 1920w","type":"image/webp","sizes":"(min-width: 1920px) 1920px, 100vw"}]},"width":1920,"height":1280}')},24663:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#e8e8d8","images":{"fallback":{"src":"/static/afeb1bc7dea09d2a9fc70292cc356d19/50965/cardiacablation.jpg","srcSet":"/static/afeb1bc7dea09d2a9fc70292cc356d19/4828c/cardiacablation.jpg 159w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/a54f2/cardiacablation.jpg 318w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/50965/cardiacablation.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/afeb1bc7dea09d2a9fc70292cc356d19/4feb0/cardiacablation.webp 159w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/60d91/cardiacablation.webp 318w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/2cd3f/cardiacablation.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},26256:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/8479fbbeb173e56a4a6e4ee260d834e2/50965/CoolCryofreezingGraphsPL.jpg","srcSet":"/static/8479fbbeb173e56a4a6e4ee260d834e2/4828c/CoolCryofreezingGraphsPL.jpg 159w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/a54f2/CoolCryofreezingGraphsPL.jpg 318w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/50965/CoolCryofreezingGraphsPL.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/8479fbbeb173e56a4a6e4ee260d834e2/4feb0/CoolCryofreezingGraphsPL.webp 159w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/60d91/CoolCryofreezingGraphsPL.webp 318w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/2cd3f/CoolCryofreezingGraphsPL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},33061:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/ec633713c452195b7772f95b03710d86/c5670/challenges-in-surgical-ablation-EN.png","srcSet":"/static/ec633713c452195b7772f95b03710d86/13212/challenges-in-surgical-ablation-EN.png 159w,\\n/static/ec633713c452195b7772f95b03710d86/81cc0/challenges-in-surgical-ablation-EN.png 318w,\\n/static/ec633713c452195b7772f95b03710d86/c5670/challenges-in-surgical-ablation-EN.png 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/ec633713c452195b7772f95b03710d86/4feb0/challenges-in-surgical-ablation-EN.webp 159w,\\n/static/ec633713c452195b7772f95b03710d86/60d91/challenges-in-surgical-ablation-EN.webp 318w,\\n/static/ec633713c452195b7772f95b03710d86/2cd3f/challenges-in-surgical-ablation-EN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},42547:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#f8f8f8","images":{"fallback":{"src":"/static/cdfa3bdc61169716f5d502ad7a59d307/c5670/CoolCryopatents.png","srcSet":"/static/cdfa3bdc61169716f5d502ad7a59d307/13212/CoolCryopatents.png 159w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/81cc0/CoolCryopatents.png 318w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/c5670/CoolCryopatents.png 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/cdfa3bdc61169716f5d502ad7a59d307/4feb0/CoolCryopatents.webp 159w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/60d91/CoolCryopatents.webp 318w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/2cd3f/CoolCryopatents.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},57203:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/ffc130f7b62bf90aca02e9aca9ef2841/50965/CoolCryoEN.jpg","srcSet":"/static/ffc130f7b62bf90aca02e9aca9ef2841/4828c/CoolCryoEN.jpg 159w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/a54f2/CoolCryoEN.jpg 318w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/50965/CoolCryoEN.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/ffc130f7b62bf90aca02e9aca9ef2841/4feb0/CoolCryoEN.webp 159w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/60d91/CoolCryoEN.webp 318w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/2cd3f/CoolCryoEN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},81145:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/b1262fef0ae2bc53b02216ace2ea3c7b/50965/CoolCryofreezingEqfreezingPL.jpg","srcSet":"/static/b1262fef0ae2bc53b02216ace2ea3c7b/4828c/CoolCryofreezingEqfreezingPL.jpg 159w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/a54f2/CoolCryofreezingEqfreezingPL.jpg 318w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/50965/CoolCryofreezingEqfreezingPL.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/b1262fef0ae2bc53b02216ace2ea3c7b/4feb0/CoolCryofreezingEqfreezingPL.webp 159w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/60d91/CoolCryofreezingEqfreezingPL.webp 318w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/2cd3f/CoolCryofreezingEqfreezingPL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},85522:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/6e04f9e39221d6150781a07c6a37d708/50965/CoolCryofreezingGraphsEN.jpg","srcSet":"/static/6e04f9e39221d6150781a07c6a37d708/4828c/CoolCryofreezingGraphsEN.jpg 159w,\\n/static/6e04f9e39221d6150781a07c6a37d708/a54f2/CoolCryofreezingGraphsEN.jpg 318w,\\n/static/6e04f9e39221d6150781a07c6a37d708/50965/CoolCryofreezingGraphsEN.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/6e04f9e39221d6150781a07c6a37d708/4feb0/CoolCryofreezingGraphsEN.webp 159w,\\n/static/6e04f9e39221d6150781a07c6a37d708/60d91/CoolCryofreezingGraphsEN.webp 318w,\\n/static/6e04f9e39221d6150781a07c6a37d708/2cd3f/CoolCryofreezingGraphsEN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},88271:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#080808","images":{"fallback":{"src":"/static/9aaeaea8a87919b3cd0dcb91805f7357/50965/atrialfibrillation.jpg","srcSet":"/static/9aaeaea8a87919b3cd0dcb91805f7357/4828c/atrialfibrillation.jpg 159w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/a54f2/atrialfibrillation.jpg 318w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/50965/atrialfibrillation.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/9aaeaea8a87919b3cd0dcb91805f7357/4feb0/atrialfibrillation.webp 159w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/60d91/atrialfibrillation.webp 318w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/2cd3f/atrialfibrillation.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},89362:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/458d2cd88fb2a5946b75ef8fdb1054db/50965/CoolCryofreezingEqfreezingEN.jpg","srcSet":"/static/458d2cd88fb2a5946b75ef8fdb1054db/4828c/CoolCryofreezingEqfreezingEN.jpg 159w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/a54f2/CoolCryofreezingEqfreezingEN.jpg 318w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/50965/CoolCryofreezingEqfreezingEN.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/458d2cd88fb2a5946b75ef8fdb1054db/4feb0/CoolCryofreezingEqfreezingEN.webp 159w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/60d91/CoolCryofreezingEqfreezingEN.webp 318w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/2cd3f/CoolCryofreezingEqfreezingEN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},96613:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/6f3a7c59af6f66dfe4399de52834e0ef/50965/CoolCryoPL.jpg","srcSet":"/static/6f3a7c59af6f66dfe4399de52834e0ef/4828c/CoolCryoPL.jpg 159w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/a54f2/CoolCryoPL.jpg 318w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/50965/CoolCryoPL.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/6f3a7c59af6f66dfe4399de52834e0ef/4feb0/CoolCryoPL.webp 159w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/60d91/CoolCryoPL.webp 318w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/2cd3f/CoolCryoPL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')}}]); 2//# sourceMappingURL=component---src-pages-products-coolcryo-tsx-305c37a7bab1d08ffd9f.js.map
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.